The rapid fat loss that these medications can induce, while beneficial for overall health and well-being, can also lead to noticeable changes in facial appearance
Instead, they recommended methylcobalamin, a form of B12 where a methyl group replaces the cyano group
The Pubmed database was searched for the following MeSH terms: glp1, glp 1, glucagon like peptide 1 receptor agonist, exenatide, lixisenatide, albiglutide, liraglutide, semaglutide or dulaglutide, and drug drug interaction or pharmacokinetic(s)
For weight loss to be sustainable, the treatment must be tolerated well enough to be used consistently over time
Substantial weight loss achieved through GLP-1 therapy might therefore improve RA symptoms by reducing this inflammatory burden
Medication can sometimes be replaced